BGPT: Paper Review: Typing of Human Enterovirus by Partial Sequencing of VP2

Explore by Goal

Quick Explanation Copied

Result (from the full-text provided)

A VP2-centered RT-PCR + partial VP2 sequencing strategy (368 bp fragment; seminested rescue) achieved high serotype concordance with seroneutralization for 61 previously typeable isolates, and for “untypeable” isolates showed VP2 vs VP1 agreement of 48/55 (87.3%) in this study.

Primary evidence:

Long Explanation

Paper Review: Typing of Human Enterovirus by Partial Sequencing of VP2

Full-text DOI: 10.1128/jcm.00093-07

Core idea: replace (or complement) VP1-based serotyping with a VP2 central fragment targeted by RT-PCR/sequencing; use seminested primers when the first PCR fails due to low infectious titer.

What this paper delivers

Primer strategy for a VP2 central region (typing fragment ~368 bp).
Concordance with seroneutralization for typeable field isolates.
Agreement between VP2 and VP1 for seroneutralization-“untypeable” isolates.

Figure 1 — Typing performance outcomes (counts explicitly stated)

Visual encoding matches the reported study counts: 61 typeable isolates with correct serotype identification vs seroneutralization, and 48/55 concordant between VP2 and VP1 among “untypeable” isolates.

Figure 2 — Decision logic the authors describe (screen → type → rescue)

Textual flow (faithful to the paper)

Verify enterovirus presence using a 5′UTR PCR (expected 152 bp band vs PV-1 reference).
Attempt VP2 first-round PCR using two primer pairs to amplify ~584 bp (PV-1 referenced), then focus sequencing on the central 368 bp fragment used for typing.
If VP2 first PCR fails, perform a seminested PCR (internal VP2 primers) to recover the typing fragment (reported expected size 368 bp in the rescue step).
Assign serotype using sequence comparisons (BLAST to GenBank sequences) and an assignment rule requiring ≥75% nucleotide identity to the prototype for serotype assignment.

Note: the paper discusses PCR sensitivity differences (first vs seminested) in terms of infectious titers.

Figure 3 — Where VP1 vs VP2 disagree in the reported “untypeables”

This breakdown comes from the results narrative: six discordant strains are those where VP1 did not amplify (EV-71 ×4; E-9 ×1; E-30 ×1), and the remaining discordant strain is described as VP1=CV-B4 and VP2=CV-B3 by sequencing and monovalent antisera, with preliminary evidence suggesting a capsid-region recombinant.

Skeptical critique (what is strong vs what remains uncertain)

Strengths

Clear comparative grounding: performance is explicitly compared against seroneutralization (for typeable isolates) and against VP1 sequencing (for “untypeable” isolates).
Rescue mechanism is mechanistically motivated by sensitivity limits; seminested amplification is used for non-amplified VP2 cases and the study reports sensitivity shifts in infectious-titer terms.
Explicit assignment criterion (≥75% nucleotide identity to prototype) reduces ambiguity relative to purely qualitative clustering.

Limitations / possible failure modes (as implied by the paper itself)

Serotype coverage is incomplete for VP2 testing: the paper states VP2 was tested on only 36 of 68 HEV serotypes, even though primers matched published sequences.
Threshold isn’t absolute: the authors emphasize that the 75% nucleotide identity cutoff is not an absolute limit and propose confirmatory comparisons when scores fall below cutoff. This indicates residual classification uncertainty near the boundary.
Recombination risk (capsid-region): a discordant strain is interpreted as a potential capsid-region recombinant (CV-B3/CV-B4), showing that VP1 vs VP2 discordance may reflect recombination rather than mere assay error.
Culture dependence: isolates are studied after virus isolation and propagation (the paper’s workflow uses cell culture supernatants and neutralization assays). That can bias which variants are recovered. The paper itself does not claim direct-from-clinical-sample typing in this work.

What would most directly falsify the approach? a systematic demonstration that VP2 typing misclassifies serotypes relative to seroneutralization/VP1 across a much wider serotype spectrum than the tested 36 serotypes, and/or that VP2 discordances frequently reflect true misassignment rather than VP1 amplification failure or recombination. The paper already reports VP1 amplification failures in some cases; those failures could either be common artifacts of primer mismatch or a real biological difference in those strains.

Practical takeaway (for lab diagnostics workflows)

A VP2 fragment can function as a routine typing screen—when paired with a rescue strategy

The study proposes VP2-based sequencing as an additional tool for HEV serotyping, especially because many isolates were typeable with a single round of VP2 PCR, while seminested PCR provides a sensitivity upgrade when amplification fails.

Author reviews (bespoke BGPT links)

Feedback:

Updated: March 28, 2026